Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $943,800 - $1.42 Million
-20,000 Reduced 66.67%
10,000 $678,000
Q3 2022

Nov 14, 2022

SELL
$31.97 - $49.37 $115,092 - $177,732
-3,600 Reduced 10.71%
30,000 $975,000
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $3.57 Million - $7.64 Million
-100,200 Reduced 74.89%
33,600 $1.32 Million
Q1 2022

May 16, 2022

BUY
$57.56 - $82.54 $6.55 Million - $9.39 Million
113,800 Added 569.0%
133,800 $9.36 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $902,400 - $1.24 Million
10,000 Added 100.0%
20,000 $1.91 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $1.06 Million - $1.57 Million
-11,300 Reduced 53.05%
10,000 $1.24 Million
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $976,178 - $1.39 Million
-9,800 Reduced 31.51%
21,300 $2.82 Million
Q3 2020

Nov 16, 2020

SELL
$72.92 - $102.01 $298,972 - $418,241
-4,100 Reduced 11.65%
31,100 $3.17 Million
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $774,925 - $1.29 Million
13,900 Added 65.26%
35,200 $3.06 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $1.91 Million - $5.25 Million
-50,300 Reduced 70.25%
21,300 $1.24 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $823,196 - $1.06 Million
-10,600 Reduced 12.9%
71,600 $6.62 Million
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $894,663 - $1.21 Million
-9,900 Reduced 10.75%
82,200 $7.43 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $1.79 Million - $2.36 Million
20,000 Added 27.74%
92,100 $10.9 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $4.21 Million - $6.55 Million
-67,900 Reduced 48.5%
72,100 $6.25 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $582,816 - $859,664
10,400 Added 8.02%
140,000 $8.83 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $1.21 Million - $2.01 Million
25,000 Added 23.9%
129,600 $10.2 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $189,200 - $349,799
5,000 Added 5.02%
104,600 $6.25 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $2.41 Million - $3.47 Million
-60,400 Reduced 37.75%
99,600 $4.02 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $1.3 Million - $1.69 Million
27,900 Added 21.12%
160,000 $8.41 Million
Q3 2017

Nov 14, 2017

BUY
$37.05 - $47.12 $4.89 Million - $6.22 Million
132,100
132,100 $6.23 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.89B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.